These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 18371020

  • 1. Concerns about "Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease".
    Corcoran B, Culshaw G, Dukes-McEwan J, French A, Smith S, Swift S.
    J Vet Intern Med; 2008; 22(2):243; author reply 245. PubMed ID: 18371020
    [No Abstract] [Full Text] [Related]

  • 2. Concerns about "Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded and randomized study".
    Le Bobinnec G.
    J Vet Intern Med; 2008; 22(2):243-4; author reply 245-6. PubMed ID: 18371019
    [No Abstract] [Full Text] [Related]

  • 3. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Ablad B, Bussadori CM, Glaus T, Kovacević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir AV, O'Sullivan ML, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2008; 22(5):1124-35. PubMed ID: 18638016
    [Abstract] [Full Text] [Related]

  • 4. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a retrospective study of 141 cases.
    Kittleson M, Rishniw M, Pion P.
    J Vet Intern Med; 2009; 23(3):445-6; author reply 447-8. PubMed ID: 19645830
    [No Abstract] [Full Text] [Related]

  • 5. Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded, and randomized study.
    Chetboul V, Lefebvre HP, Sampedrano CC, Gouni V, Saponaro V, Serres F, Concordet D, Nicolle AP, Pouchelon JL.
    J Vet Intern Med; 2007; 21(4):742-53. PubMed ID: 17708394
    [Abstract] [Full Text] [Related]

  • 6. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial.
    Boswood A, Häggström J, Gordon SG, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Watson P.
    J Vet Intern Med; 2016 Nov; 30(6):1765-1779. PubMed ID: 27678080
    [Abstract] [Full Text] [Related]

  • 7. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K.
    J Vet Intern Med; 2013 Nov; 27(6):1452-62. PubMed ID: 24128373
    [Abstract] [Full Text] [Related]

  • 8. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: A retrospective study of 141 cases.
    Kittleson M, Rishniw M, Pion P, Kass P.
    J Vet Intern Med; 2009 Nov; 23(5):953-4; author reply 955-6. PubMed ID: 19737176
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safet of pimobendan in canine heart failure caused by myxomatous mitral valve disease.
    Smith PJ, French AT, Van Israël N, Smith SG, Swift ST, Lee AJ, Corcoran BM, Dukes-McEwan J.
    J Small Anim Pract; 2005 Mar; 46(3):121-30. PubMed ID: 15789807
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical mitral valve disease.
    Boswood A, Smith S, Patteson M.
    Vet Rec; 2011 Feb 26; 168(8):222. PubMed ID: 21493561
    [No Abstract] [Full Text] [Related]

  • 11. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Åblad B, Bussadori CM, Glaus T, Kovačević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir A, Lynne O'Sullivan M, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2013 Feb 26; 27(6):1441-51. PubMed ID: 24010489
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of pimobendan and N-terminal probrain natriuretic peptide in the treatment of pulmonary hypertension secondary to degenerative mitral valve disease in dogs.
    Atkinson KJ, Fine DM, Thombs LA, Gorelick JJ, Durham HE.
    J Vet Intern Med; 2009 Feb 26; 23(6):1190-6. PubMed ID: 19780931
    [Abstract] [Full Text] [Related]

  • 13. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs.
    Lombard CW, Jöns O, Bussadori CM.
    J Am Anim Hosp Assoc; 2006 Feb 26; 42(4):249-61. PubMed ID: 16822763
    [Abstract] [Full Text] [Related]

  • 14. Benazepril in dogs with asymptomatic mitral valve disease.
    Brennan M, Stavisky J.
    Vet Rec; 2015 Oct 17; 177(15):392. PubMed ID: 26475899
    [Abstract] [Full Text] [Related]

  • 15. Effects of pimobendan for mitral valve regurgitation in dogs.
    Kanno N, Kuse H, Kawasaki M, Hara A, Kano R, Sasaki Y.
    J Vet Med Sci; 2007 Apr 17; 69(4):373-7. PubMed ID: 17485924
    [Abstract] [Full Text] [Related]

  • 16. Investigation of pimobendan versus benazepril in canine myxomatous valvular disease.
    Boswood A, McEwan JD, French A, Little C, Swift S, Smith S, Patteson M.
    Vet Rec; 2003 Oct 04; 153(14):439-40. PubMed ID: 14582738
    [No Abstract] [Full Text] [Related]

  • 17. Long-term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy.
    Vollmar AC, Fox PR.
    J Vet Intern Med; 2016 Oct 04; 30(2):553-9. PubMed ID: 26936799
    [Abstract] [Full Text] [Related]

  • 18. A QUEST begins.
    Oyama MA.
    J Vet Intern Med; 2008 Oct 04; 22(5):1076-8. PubMed ID: 18844829
    [No Abstract] [Full Text] [Related]

  • 19. Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.
    de Madron E, King JN, Strehlau G, White RV.
    Can Vet J; 2011 Nov 04; 52(11):1219-25. PubMed ID: 22547843
    [Abstract] [Full Text] [Related]

  • 20. Current use of pimobendan in canine patients with heart disease.
    Boswood A.
    Vet Clin North Am Small Anim Pract; 2010 Jul 04; 40(4):571-80. PubMed ID: 20610012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.